NCT06022276 2023-09-01Nimotuzumab for EGFR-amplified Advanced Pan Solid TumorsTianjin Medical University Second HospitalPhase NA Unknown46 enrolled
NCT01393080 2016-02-17NSCLCTianjin Medical University Cancer Institute and HospitalPhase NA Unknown160 enrolled